186689-75-8

Upstream product

• 186689-81-6 3-oxo-7-phenyl-heptanal 
• 186689-73-6 (E)-1-chloro-7-phenyl-1-hepten-3-one 
• 14171-89-2 1-phenyl-5-hexanone 
• 186689-74-7 (E)-1-iodo-7-phenyl-1-hepten-3-one 

Downstream Products

• 183872-18-6 3-[(E)-3-tert-butyldimethylsilyloxy-7-phenyl-1-hepten-1-yl]cyclohexanone 
• 186689-76-9 tert-Butyl-[1-((E)-2-iodo-vinyl)-5-phenyl-pentyloxy]-dimethyl-silane 

Relevant academic research and scientific papers

Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*,3S*)-1-hydroxy-3-[(3 R*S*, E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate

A novel series of leukotriene B4 (LTB4) antagonists is reported. These compounds present a cyclohexane ring in their chemical structure, which mimics the three conjugated double bonds of LTB4. The biochemical/pharmacologic

3-Substituted iodo alkenyl compounds and methods for preparing same

Compounds of the formula: SPC1 Where R is hydrogen, methyl or ethyl; R' is hydrogen, a saturated hydrocarbon chain containing from 1 to about 9 carbon atoms, pentene, hexene, cyclohexyl, or benzyl X is hydrogen, pyranoxy, OR" where R" is a hydrocarbon chain containing from 1 to about 5 carbon atoms or benzyl, EQU1 where R"' is a hydrocarbon chain containing from 1 to about 8 carbon atoms or benzyl, or EQU2 where R1 and R2 are each a hydrocarbon chain containing from 1 to about 5 carbon atoms, and n is an integer from 0 to 5 These compounds are key intermediates in the production of prostaglandins and exhibit antibacterial properties.